---
title: Slice 135 independent closeout review — 2026-10-08
status: APPROVE_WITH_EXPLICIT_LIMITATIONS
target_release: 0.8.27
---

# Slice 135 independent closeout review — 2026-10-08

An independent read-only agent reviewed the branch against
`release/0.8.27`, the approved [plan](plan.md), the Phase 1, Phase 2 and GPU
reports, and the proposed [final disposition](status.md). It inspected the
material row-error propagation changes in `search.rs` and `fusion.rs` with
their failing-first tests and receipts. The reviewer found no concrete
product-code defect: the new optional-row handling preserves a genuine
no-row result while propagating SQL and decode failures as storage errors.
The measured product tree still matches `224e44c59`.

**Verdict: approve closeout as a diagnostic measurement/disposition slice
with explicit limitations.** The reviewer agreed that Phase 2's approved
rule permits evidence-backed unsupported cells, and that Phase 1's recorded
sequencing disposition places CPU/queue, sustained-load, fault and platform
gaps in follow-up work. The status must not claim full qualification of those
cells, release artifacts, or the final 0.8.27 integrated candidate.

Review scope was the named product changes, tests, plan and reports. The
reviewer did not audit all 266 branch commits or independently recompute
every raw sample. The independent per-cell auditors and manifest checks in
the linked reports supply those narrower verification claims. Archive
integrity, scoped validators and release-state synchronization remain
separate operational closeout checks.
